RVL Pharmaceuticals plc (RVLP) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 31 transactions totaling $40.4M, demonstrating a bullish sentiment with $37.1M in net insider flow. The most recent transaction on Oct 20, 2023 involved a sale of 4,758,899 shares valued at $142.8K.
No significant insider buying has been recorded for RVLP in the recent period.
No significant insider selling has been recorded for RVLP in the recent period.
Based on recent SEC filings, insider sentiment for RVLP is bullish with an Insider Alignment Score of 96/100 and a net flow of $37.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at RVL Pharmaceuticals plc (RVLP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading RVLP stock, having executed 31 transactions in the past 90 days. The most active insider is Co-invest III Llc Orbit (Executive), who has made 2 transactions totaling $12.4M.
Get notified when executives and directors at RVLP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 20, 2023 | Altchem Ltd | Executive | Sale | 4,758,899 | $0.03 | $142.8K | |
| Oct 20, 2023 | Harsaul Foundation | Executive | Sale | 4,758,899 | $0.03 | $142.8K | |
| Oct 19, 2023 | Altchem Ltd | Executive | Sale | 9,363,760 | $0.05 | $468.2K | |
| Oct 19, 2023 | Harsaul Foundation | Executive | Sale | 9,363,760 | $0.05 | $468.2K | |
| Oct 18, 2023 | Altchem Ltd | Executive | Sale | 3,421,537 | $0.06 | $205.3K | |
| Oct 18, 2023 | Harsaul Foundation | Executive | Sale | 3,421,537 | $0.06 | $205.3K | |
| Aug 15, 2023 | Partners Gp, Ltd. Avista Healthcare | Executive | Other | 23,730,864 | $N/A | $0 | |
| Aug 10, 2023 | Lask Alisa | Executive | Payment | 12,000 | $0.49 | $5.9K | |
| Jul 5, 2023 | Lask Alisa | Executive | Award | 40,000 | $N/A | $0 | |
| Jul 5, 2023 | L. Cowan Gregory | Executive | Award | 40,000 | $N/A | $0 | |
| Jul 5, 2023 | J. Debiasi Michael | Executive | Award | 40,000 | $N/A | $0 | |
| May 18, 2023 | Klein Christopher | Executive | Payment | 5,447 | $0.87 | $4.7K | |
| May 18, 2023 | Schaub James | Executive | Payment | 5,577 | $0.87 | $4.9K | |
| Jan 27, 2023 | III Llc Orbit Co-invest | Executive | Other | 1,032,995 | $N/A | $0 | |
| Jan 27, 2023 | Venkataraman Sriram | Executive | Other | 1,032,995 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $38.8M | 95.7% |
Sale(S) | 6 | $1.6M | 4.0% |
Payment(F) | 12 | $108.1K | 0.3% |
Other(J) | 4 | $0 | 0.0% |
Award(A) | 4 | $0 | 0.0% |
Insiders at RVL Pharmaceuticals plc are accumulating shares at an accelerated pace. With 14 insiders making 31 transactions totaling $38.8M in purchases versus $1.6M in sales, the net buying activity of $37.1M signals strong executive confidence. Co-invest III Llc Orbit (Executive) leads the buying activity with $12.4M in transactions across all time.